Sookja K Chung Selected Research

Ischemic Stroke

10/2015	Selective astrocytic endothelin-1 overexpression contributes to dementia associated with ischemic stroke by exaggerating astrocyte-derived amyloid secretion.
7/2010	More severe type 2 diabetes-associated ischemic stroke injury is alleviated in aldose reductase-deficient mice.
8/2005	Endothelin-1 overexpression leads to further water accumulation and brain edema after middle cerebral artery occlusion via aquaporin 4 expression in astrocytic end-feet.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sookja K Chung Research Topics

Disease

11	Ischemia 01/2016 - 08/2005
7	Infarction (Infarctions) 01/2020 - 08/2005
5	Pain (Aches) 01/2018 - 10/2012
5	Obesity 04/2017 - 10/2010
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2010 - 11/2004
4	Stroke (Strokes) 11/2019 - 08/2005
4	Hyperalgesia 01/2018 - 01/2012
4	Neuralgia (Stump Neuralgia) 01/2018 - 01/2013
4	Brain Ischemia (Cerebral Ischemia) 01/2017 - 01/2008
4	Androgen-Insensitivity Syndrome (Testicular Feminization) 01/2017 - 11/2005
4	Alzheimer Disease (Alzheimer's Disease) 10/2015 - 01/2011
4	Edema (Dropsy) 10/2013 - 11/2007
3	Diabetic Neuropathies (Diabetic Neuropathy) 01/2018 - 08/2003
3	Ischemic Stroke 10/2015 - 08/2005
3	Hyperglycemia 10/2013 - 08/2003
2	Parkinson Disease (Parkinson's Disease) 01/2018 - 01/2017
2	Hypoxia (Hypoxemia) 10/2015 - 08/2005
2	Dementia (Dementias) 10/2015 - 03/2013
2	Inflammation (Inflammations) 08/2014 - 01/2012
2	Wounds and Injuries (Trauma) 08/2014 - 07/2010
2	Reperfusion Injury 08/2014 - 01/2012
2	Neuroblastoma 01/2014 - 12/2012
2	Insulin Resistance 10/2013 - 02/2011
2	Gliosis 03/2013 - 12/2012
2	Hypertension (High Blood Pressure) 03/2013 - 11/2007
2	Cataract (Cataracts) 11/2008 - 10/2006
2	Diabetes Complications 06/2008 - 10/2006
2	Atherosclerosis 11/2007 - 12/2004
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Neoplasms (Cancer) 10/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Blister (Bulla) 01/2017
1	Optic Nerve Injuries 01/2017
1	Crush Injuries 01/2016
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2016
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 09/2015
1	Blindness (Hysterical Blindness) 09/2015

Drug/Important Bio-Agent (IBA)

14	Aldehyde Reductase (Aldose Reductase)IBA 01/2018 - 08/2003
13	Endothelin-1 (Endothelin 1)IBA 11/2019 - 11/2004
8	polyolIBA 01/2021 - 08/2003
6	Retinaldehyde (Retinal)IBA 09/2015 - 11/2005
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2012
5	Vasoconstrictor AgentsIBA 11/2014 - 08/2005
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2010
4	Amyloid (Amyloid Fibrils)IBA 10/2015 - 01/2011
4	Peptides (Polypeptides)IBA 01/2014 - 01/2011
4	L-Iditol 2-Dehydrogenase (L Iditol 2 Dehydrogenase)IBA 09/2010 - 11/2007
3	Messenger RNA (mRNA)IBA 01/2018 - 08/2005
3	EnzymesIBA 09/2010 - 08/2003
2	cyclo(Trp-Asp-Pro-Val-Leu)IBA 01/2018 - 01/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017 - 11/2005
2	ManganeseIBA 01/2017 - 01/2008
2	ChemokinesIBA 01/2016 - 08/2014
2	Endothelins (Endothelin)IBA 10/2015 - 01/2013
2	Caspase 3 (Caspase-3)IBA 10/2015 - 03/2013
2	Glutamic Acid (Glutamate)FDA Link 09/2015 - 01/2011
2	BerberineIBA 01/2014 - 12/2012
2	AtrasentanIBA 10/2013 - 08/2005
2	Formaldehyde (Formol)FDA Link 10/2012 - 01/2012
2	Glial Fibrillary Acidic ProteinIBA 01/2011 - 08/2005
2	Aquaporin 4IBA 07/2010 - 08/2005
2	Superoxides (Superoxide)IBA 04/2009 - 07/2006
2	OccludinIBA 04/2009 - 08/2005
2	Glutathione (Reduced Glutathione)IBA 11/2008 - 07/2006
2	Sorbitol (Yal)FDA Link 11/2008 - 10/2006
1	NAD (NADH)IBA 01/2021
1	Tight Junction ProteinsIBA 01/2020
1	Fatty Acid-Binding ProteinsIBA 01/2020
1	AdipokinesIBA 01/2020
1	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 11/2019
1	ChloridesIBA 11/2019
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	NF-kappa B (NF-kB)IBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	ProstaglandinsIBA 04/2017
1	CollagenIBA 01/2017
1	PyrrolidinesIBA 01/2017
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2017
1	fluorocitrateIBA 01/2016
1	prostaglandin-inositol cyclic phosphateIBA 01/2016
1	plerixafor FDA Link 01/2016
1	N-(1,4,8,11- tetraazacyclotetradecanyl- 1,4- phenylenebis(methylene))- 2- (aminomethyl)- pyridineIBA 01/2016
1	Minocycline (Cyclops)FDA LinkGeneric 01/2016
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2016
1	CXC ChemokinesIBA 01/2016
1	Chemokine CXCL12IBA 01/2016
1	thioflavin TIBA 10/2015
1	Excitatory Amino AcidsIBA 09/2015
1	Thromboxane Receptors (Thromboxane Receptor)IBA 11/2014
1	Chemotactic FactorsIBA 08/2014
1	CytokinesIBA 08/2014
1	huang-lien-chieh-tu-tangIBA 01/2014
1	oren gedoku toIBA 01/2014
1	AlkaloidsIBA 01/2014

Therapy/Procedure

3	Ligation 01/2018 - 01/2013
2	Liver Transplantation 01/2017 - 08/2014
1	Therapeutics 01/2016